{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T22:30:44Z","timestamp":1649197844230},"reference-count":34,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":295,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"name":"Dust Diseases Board Research Grant","award":["n\/a"],"award-info":[{"award-number":["n\/a"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Asia-Pac J Clin Oncol"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1111\/ajco.12306","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T11:13:13Z","timestamp":1415617993000},"page":"85-92","source":"Crossref","is-referenced-by-count":4,"title":["Estimation of an optimal chemotherapy utilization rate for malignant pleural mesothelioma: An evidence-based benchmark for cancer care"],"prefix":"10.1111","volume":"11","author":[{"given":"Steven Chuan-Hao","family":"Kao","sequence":"first","affiliation":[{"name":"Asbestos Diseases Research Institute; Sydney New South Wales Australia"},{"name":"Department of Medical Oncology; Chris O'Brien Lifehouse; Sydney New South Wales Australia"},{"name":"Sydney Medical School; The University of Sydney; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"van Zandwijk","sequence":"additional","affiliation":[{"name":"Asbestos Diseases Research Institute; Sydney New South Wales Australia"},{"name":"Sydney Medical School; The University of Sydney; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Clarke","sequence":"additional","affiliation":[{"name":"Sydney Medical School; The University of Sydney; Sydney New South Wales Australia"},{"name":"Department of Medical Oncology; Royal North Shore Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janette","family":"Vardy","sequence":"additional","affiliation":[{"name":"Sydney Medical School; The University of Sydney; Sydney New South Wales Australia"},{"name":"Concord Cancer Centre; Concord Repatriation General Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumit","family":"Lumba","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Liverpool Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annette","family":"Tognela","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Liverpool Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weng","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology; Liverpool Hospital; Sydney New South Wales Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,11,10]]},"reference":[{"key":"10.1111\/ajco.12306-BIB0001|ajco12306-cit-0001","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(05)67025-0","article-title":"Malignant mesothelioma","volume":"366","author":"Robinson","year":"2005","journal-title":"Lancet"},{"key":"10.1111\/ajco.12306-BIB0002|ajco12306-cit-0002","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1445-5994.2010.02223.x","article-title":"Malignant mesothelioma","volume":"40","author":"Kao","year":"2010","journal-title":"Intern Med J"},{"key":"10.1111\/ajco.12306-BIB0003|ajco12306-cit-0003","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajco.12306-BIB0004|ajco12306-cit-0004","doi-asserted-by":"crossref","first-page":"6881","DOI":"10.1200\/JCO.20005.14.589","article-title":"Randomized phase III study of cisplatin with or without raltitrexed in patients with malignant pleural mesothelioma: an intergroup study of the European Organisation for Research and Treatment of Cancer Lung Cancer Group and the National Cancer Institute of Canada","volume":"23","author":"Meerbeeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1111\/ajco.12306-BIB0005|ajco12306-cit-0005","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/01243894-200607000-00017","article-title":"The use of chemotherapy in patients with advanced malignant pleural mesothelioma: a systemic review and practice guideline","volume":"1","author":"Ellis","year":"2006","journal-title":"J Thorac Oncol"},{"key":"10.1111\/ajco.12306-BIB0006|ajco12306-cit-0006","first-page":"Abstract 2496","article-title":"Improving quality of life in patients with malignant pleural mesothelioma: results of the randomized pemetrexed\u2009+\u2009cisplatin vs. cisplatin trial using the LCSS-meso instrument","volume":"22","author":"Gralla","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1111\/ajco.12306-BIB0007|ajco12306-cit-0007","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1002\/ijc.2910410409","article-title":"Survival patterns for malignant mesothelioma: the SEER experience","volume":"41","author":"Spirtas","year":"1988","journal-title":"Int J Cancer"},{"key":"10.1111\/ajco.12306-BIB0008|ajco12306-cit-0008","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.lungcan.2008.09.008","article-title":"Outcomes with first-line platinum-based combination chemotherapy for malignant pleural mesothelioma: a review of practice in British Columbia","volume":"64","author":"Lee","year":"2009","journal-title":"Lung Cancer"},{"key":"10.1111\/ajco.12306-BIB0009|ajco12306-cit-0009","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1136\/thx.2007.081430","article-title":"Population based epidemiology and prognosis of mesothelioma in Leeds, UK","volume":"63","author":"Chapman","year":"2008","journal-title":"Thorax"},{"key":"10.1111\/ajco.12306-BIB0010|ajco12306-cit-0010","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1445-5994.2012.02925.x","article-title":"Patterns of care for malignant pleural mesothelioma patients compensated by the Dust Diseases Board in New South Wales of Australia","volume":"43","author":"Kao","year":"2012","journal-title":"Intern Med J"},{"key":"10.1111\/ajco.12306-BIB0011|ajco12306-cit-0011","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s004200100240","article-title":"Malignant mesothelioma - German mesothelioma register 1987-1999","volume":"74","author":"Neumann","year":"2001","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1111\/ajco.12306-BIB0012|ajco12306-cit-0012","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.1445-5994.1993.tb00532.x","article-title":"Clinical aspects of malignant mesothelioma in Australia","volume":"23","author":"Driscoll","year":"1993","journal-title":"Aust N Z J Med"},{"key":"10.1111\/ajco.12306-BIB0013|ajco12306-cit-0013","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1183\/09031936.00153611","article-title":"Population-based survival for malignant mesothelioma after introduction of novel chemotherapy","volume":"40","author":"Damhuis","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1111\/ajco.12306-BIB0014|ajco12306-cit-0014","doi-asserted-by":"crossref","first-page":"26","DOI":"10.6004\/jnccn.2012.0006","article-title":"Malignant pleural mesothelioma","volume":"10","author":"Ettinger","year":"2010","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1111\/ajco.12306-BIB0015|ajco12306-cit-0015","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/thx.2007.087619","article-title":"BTS statement on malignant mesothelioma in the UK, 2007","volume":"62","author":"British Thoracic Society Standards of Care Committee","year":"2007","journal-title":"Thorax"},{"key":"10.1111\/ajco.12306-BIB0016|ajco12306-cit-0016","doi-asserted-by":"crossref","first-page":"v126","DOI":"10.1093\/annonc\/mdq173","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"21","author":"Stahel","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1111\/ajco.12306-BIB0017|ajco12306-cit-0017","first-page":"479","article-title":"Guidelines of the european respiratory society and the european society of thoracic surgeons for management of malignant pleural mesothelioma","author":"Scherpereel","year":"2009","journal-title":"Eur Respir J"},{"key":"10.1111\/ajco.12306-BIB0018|ajco12306-cit-0018","unstructured":"National Cancer Institute PDQ cancer information summaries: malignant mesothelioma treatment 2013 http:\/\/www.nci.nih.gov"},{"key":"10.1111\/ajco.12306-BIB0019|ajco12306-cit-0019","unstructured":"BC Cancer Agency Cancer management guidelines for malignant mesothelioma 2001 http:\/\/www.bccancer.bc.ca\/HPI\/CancerManagementGuidelines\/Lung\/Mesothelioma\/default.htm"},{"key":"10.1111\/ajco.12306-BIB0020|ajco12306-cit-0020","unstructured":"National Health and Medical Research Council (NHMRC) A guide to the development, implementation and evaluation of clinical practice guidelines 1999"},{"key":"10.1111\/ajco.12306-BIB0021|ajco12306-cit-0021","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1097\/JTO.0b013e3181f1903e","article-title":"Frequency of use and predictors of cancer-directed surgery in the management of malignant pleural mesothelioma in a community-based (Surveillance, Epidemiology, and End Results [SEER]) population","volume":"5","author":"Flores","year":"2010","journal-title":"J Thorac Oncol"},{"key":"10.1111\/ajco.12306-BIB0022|ajco12306-cit-0022","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1002\/cncr.21324","article-title":"The role of radiotherapy in cancer treatment. Estimating optimal utilization from a review of evidence-based clinical guidelines","volume":"104","author":"Delaney","year":"2005","journal-title":"Cancer"},{"key":"10.1111\/ajco.12306-BIB0023|ajco12306-cit-0023","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.lungcan.2009.11.017","article-title":"Estimation of an optimal chemotherapy utilisation rate for lung cancer: an evidence-based benchmark for cancer care","volume":"69","author":"Jacob","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1111\/ajco.12306-BIB0024|ajco12306-cit-0024","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clon.2010.08.011","article-title":"Estimation of an optimal chemotherapy utilisation rate for primary malignant brain tumours: an evidence-based benchmark for cancer care","volume":"23","author":"Jacob","year":"2011","journal-title":"Clin Oncol"},{"key":"10.1111\/ajco.12306-BIB0025|ajco12306-cit-0025","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1016\/j.ejca.2009.05.023","article-title":"Estimation of an optimal chemotherapy utilisation rate for colon cancer: an evidence-based benchmark for cancer care","volume":"45","author":"Jacob","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1111\/ajco.12306-BIB0026|ajco12306-cit-0026","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.ejca.2009.12.002","article-title":"Estimation of an optimal chemotherapy utilisation rate for breast cancer: setting an evidence-based benchmark for the best-quality cancer care","volume":"46","author":"Ng","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1111\/ajco.12306-BIB0027|ajco12306-cit-0027","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.ejca.2009.02.007","article-title":"Estimation of an optimal chemotherapy utilisation rate for head and neck carcinoma: setting an evidence-based benchmark for the best-quality cancer care","volume":"45","author":"Ng","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1111\/ajco.12306-BIB0028|ajco12306-cit-0028","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the Mesothelioma and Radical Surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1111\/ajco.12306-BIB0029|ajco12306-cit-0029","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S1470-2045(11)70307-2","article-title":"The MARS feasibility trial: conclusions not supported by data","volume":"12","author":"Weder","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1111\/ajco.12306-BIB0030|ajco12306-cit-0030","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/S0140-6736(11)60780-0","article-title":"Carboplatin and weekly doublet chemotherapy compared with monotherapy in elderly patients with advanced non-small-cell lung cancer. IFCT-0501 randomised, phase 3 trial","volume":"378","author":"Quoix","year":"2011","journal-title":"Lancet"},{"key":"10.1111\/ajco.12306-BIB0031|ajco12306-cit-0031","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/jnci\/95.5.362","article-title":"Chemotherapy for elderly patients with advanced non-small-cell lung cancer; the Multicenter Italian Lung Cancer in the Elderly Study (MILES) phase III randomized trial","volume":"95","author":"Grideli","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/ajco.12306-BIB0032|ajco12306-cit-0032","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.lungcan.2010.05.001","article-title":"Patients' preferences for chemotherapy in non-small-cell lung cancer: a systematic review","volume":"69","author":"Blinman","year":"2010","journal-title":"Lung Cancer"},{"key":"10.1111\/ajco.12306-BIB0033|ajco12306-cit-0033","first-page":"1183","article-title":"A very public death: dying of mesothleioma and asbestos-related lung cancer (M\/ARLC) in the Latrobe Valley, Victoria, Australia","volume":"9","author":"Lee","year":"2009","journal-title":"Rural Remote Health"},{"key":"10.1111\/ajco.12306-BIB0034|ajco12306-cit-0034","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/j.1365-2354.2009.01162.x","article-title":"Living with mesothelioma. A literature review","volume":"19","author":"Moore","year":"2009","journal-title":"Eur J Cancer Care"}],"container-title":["Asia-Pacific Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fajco.12306","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ajco.12306\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,3]],"date-time":"2021-07-03T08:39:40Z","timestamp":1625301580000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ajco.12306"}},"subtitle":["Chemotherapy utilization in mesothelioma"],"short-title":[],"issued":{"date-parts":[[2014,11,10]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,3]]}},"URL":"https:\/\/doi.org\/10.1111\/ajco.12306","relation":{},"ISSN":["1743-7555"],"issn-type":[{"value":"1743-7555","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11,10]]}}}